Africa Medical Cannabis Market, by Derivative

Growth Outlook

• The Africa Medical Cannabis Market, by Derivative market is on a steady long-term growth path. Segment value stands at roughly USD 568 Mn in 2026 and is projected to reach USD 735 Mn by 2027 — a gain of about 29% over the forecast period, translating to a CAGR in the double digits.
• What the regional split looks like (2026): Cannabidiol leads, holding roughly 72% of segment value — the single largest regional share. Tetrahydrocannabinol is the second-largest contributor.
• By 2027, Cannabidiol alone is expected to reach USD 529 Mn, with Tetrahydrocannabinol at USD 206 Mn.

Market Dynamics

Africa, often referred to as the “dark continent”, has long been associated with war, poverty, and instability. However, recent years have seen a significant shift in perception, as it has emerged as a promising market for medical cannabis.

The medical cannabis market in Africa is primarily driven by the growing awareness and acceptance of the potential health benefits of cannabis. Traditional African medicine has long utilized cannabis as a remedy for various ailments, and this knowledge is now being recognized and supported by modern scientific research.

One of the key drivers of the medical cannabis market in Africa is the growing demand for derivative products. Derivatives are products made from cannabis extracts such as oils, tinctures, and edibles, which are believed to have higher potency and longer-lasting effects than traditional cannabis products. These derivative products are seen as a natural and holistic alternative to chemically manufactured medicines, and are therefore gaining popularity among African consumers.

Another factor contributing to the rise in demand for medical cannabis derivatives in Africa is the increasing support from governments and regulatory bodies. Many African countries have either decriminalized or legalized cannabis for medicinal purposes, signaling a growing acceptance of the plant's potential benefits. This has created a more conducive environment for medical cannabis companies to operate in and has opened up opportunities for research and development of new derivative products.

In addition to this, the presence of a large and growing population also adds to the demand for medical cannabis derivatives in Africa. With over 1.3 billion people, Africa accounts for 16% of the global population, and this number is expected to double by 2050. As such, there is a significant market for medical cannabis products, especially in countries with high rates of chronic illnesses such as HIV/AIDS, cancer, and epilepsy.

Furthermore, the diversity of African cultures and traditions also contributes to the demand for medical cannabis derivatives. Different cultures and traditions have different ways of using and preparing cannabis for medicinal purposes, and this has created a demand for a wide range of derivative products that cater to these unique needs.